Angelica archangelica extract ameliorates the oxidative stress induced by Pseudomonas aeruginosa in rats
DOI:
https://doi.org/10.56511/JIPBS.2020.v7.i04.pp01-12Abstract
This study investigated the influence of Angelica archangelica roots aqueous extract on Pseudomonas aeruginosa bacteria. The antimicrobial activity of different concentrations of Angelica was assessed in vitro on two strains of yeast and two strains of fungi. P. aeruginosa antibiotics resistance was confirmed against three antibiotics. Results demonstrated that Angelica had very high activity on the growth of P. aeruginosa. To confirm this activity in vivo, four groups of male wistar albino rats were used. Control group received water only, infection group subjected to bacterial infection for two weeks, treatment group subjected to bacterial infection for two weeks followed by oral administration of Angelica archangelica roots extract for two other weeks and protection group subjected to bacterial infection with oral administration of Angelica archangelica extract for two weeks. At the end of experiment, histopathological examination of kidney and liver specimens was carried out; also blood samples were collected to measure biochemical and oxidative stress parameters. Amelioration of the histological images of both the liver and kidney were observed in both group 3 &4. Biochemical results showed significant enhancement in all parameters measured in group 3 & 4 as compared to group 2. Results were more abundant in group 4 than group 3. In conclusion, Angelica archangelica roots aqueous extract has the potential to remove the oxidative stress caused by P. aeruginosa which resulted in enhancement of histopathological and biochemical results.
Keywords:
Angelica archangelica, Pseudomonas aeruginosa, Antibacterial, AntioxidantDownloads
References
Daneman N, Elligsen M, Walker SA and Simor A: Duration of hospital admission and the need for empirical antipseudomonal therapy. Journal of clinical microbiology 2012; 50(8):2695-2701.
Poole K: Pseudomonas aeuriginosa: resistant to the max. Front microbial. 2011; 2-6.
Hentges DJ, STEM AJ, Case SW and Onderdon KA: Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: Influence of antibiotics on colonization resistance. Infect. Immune. 1980; 47: 118-122.
Nakamura I., Yamaguchi T., Tsukimori A., Sato A., Fukushima S, Mizuno Y and Matsumoto T: Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use. Journal of Infection and Chemotherapy 2014; 20(4):266-269.
Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S and Greenberg EP: Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001; 413(6858):860-864.
Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N and Yamaguchi K: Oral administration of Bifidobacterium longum prevents gut ‐ derived Pseudomonas aeruginosa sepsis in mice. Journal of applied microbiology 2008; 104(3):672-680.
Bonjar GS, Nik AK. Antibacterial activity of some medicinal plants of Iran against Pseudomonas aeruginosa and P. fluorescens. Asian Journal of Plant Sciences 2004; 3:61-64.
Radji M, Agustama RA, Elya B and Tjampakasari CR: Antimicrobial activity of green tea extract against isolates of methicillin – resistant Staphylococcus aureus and multi – drug resistant Pseudomonas aeruginosa. Asian Pacific journal of tropical biomedicine 2013; 3(8):663-667.
Al-Mariri A and Safi M: In vitro antibacterial activity of several plant extracts and oils against some gram-negative bacteria. Iranian journal of medical sciences 2014; 39(1):36-43.
Cragg GM, Newman DJ and Snader KM: Natural products in drug discovery and development. J. Natural Prod. 1997; 60:52-60.
Sarker SD and Nahar L: Natural medicine: the genus Angelica. Current medicinal chemistry 2004; 11(11):1479-1500.
Nivinskiene O, Butkiene R and Mockutë D: Changes in the chemical composition of essential oil of Angelica archangelica L. roots during storage. Chemija (Vilnius). 2003; 14(1):52-56.
Reygaert WC: The antimicrobial possibilities of green tea. Frontiers in microbiology 2014; 5: 434-438.
Sharma A, Gupta S, Sarethy IP, Dang S and Gabrani R: Green tea extract: possible mechanism and antibacterial activity on skin pathogens. Food chemistry 2012; 135(2):672-675.
Ramachandran G: Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence. 2014; 5(1):213-218.
Bassem MR, Abd El-Baset MS, and Amira SR: Using of Angelica officinalis roots powder as a chelating agent of lead in rats. Medical J Cairo University 2005; 149-156.
Harrigan WF: Laboratory Methods in Food Microbiolgy. 3rd Edh. Academic Press, San Digo, London, Boston, New York, Sydney, Tokyo and Toronto. (1998).
Barry AL: Procedure for testing antimicrobial agents in agar medium: Theoretical considerations. In: Antibiotics in laboratory medicine, (Ed, V. Lorian). Williams & Wilkins, the University of Michigan, US. (1986) 1-26.
Drury RAB and Wallington FA: Corleton’s Histological Technique 4th Ed. Oxford, New York, Toronto, Oxford university press. (1980) 520.
Beutler E: Improved method for the determination of blood glutathione. J. lab. Clin. Med. 1963; 61:882-888.
Kei S: Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica chimica acta 1978; 90(1):37-43.
Nishikimi M, Rao NA and Yagi K: The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochemical and biophysical research communications 1972; 46(2):849-54.
Goldberg D.M and Spooner RJ: Methods of Enzymatic analysis (Brgmeyen, HV ED). Verlog Chemie, Deerfield beach, Fl. 3rd edn. Vol. 3. (1983) 258-256.
Aebi H: Catalase in vitro. Methods in enzymology 1984; 105:121126). Academic Press.
Paglia DE and Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The Journal of laboratory and clinical medicine 1967; 70(1):158-169.
Habig WH, Pabst MJ and Jakoby WB: Glutathione S-transferases the first enzymatic step in mercapturic acid formation. Journal of biological Chemistry 1974; 249(22):7130-7139.
Reitman S and Frankel S: A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American journal of clinical pathology. 1957; 28(1):56-63.
Bartels H, Böhmer M, Heierli C. Serum creatinine determination without protein precipitation. Clinica chimica acta; international journal of clinical chemistry 1972; 37:193.
Coggan KA and Wolfgang MC: Global regulatory pathways and cross-talk control Pseudomonas aeruginosa environmental lifestyle and virulence phenotype. Current issues in molecular biology 2012; 14(2):47-70.
Pirnay JP, Matthijs S, Colak H, Chablain P, Bilocq F, Van Eldere J, De Vos D, Zizi M, Triest L and Cornelis P: Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river. Environmental microbiology 2005; 7(7):969-80.
Meinke G, Barum J, Rosenberg B and Berk R: In vivo studies with the partially purified protease (elastase) from Pseudomonas aeruginosa. Infection and immunity 1970; 2(5):583-589.
Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daures JP and Sotto A: Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. Journal of Hospital Infection 2004; 57(3):209-216.
Brown SP, Cornforth DM and Mideo N: Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends in microbiology 2012; 20(7):336-342.
Engel J and Balachandran P: Role of Pseudomonas aeruginosa type III effectors in disease. Current opinion in microbiology 2009; 12(1):6166.
Bodey GP: Microbiologic aspects in patients with leukemia. Human pathology 1974; 5(6):687-698.
Koch C and Hoiby N: Pathogenesis of cystic fibrosis. Lancet 1993; 341:1065-1069.
Huhulescu S, Simon M, Lubnow M, Kaase M, Wewalka G, Pietzka AT, Stöger A, Ruppitsch W and Allerberger F: Fatal Pseudomonas aeruginosa pneumonia in a previously healthy woman was most likely associated with a contaminated hot tub. Infection 2011; 39(3):265-269.
Hatchette TF, Gupta R and Marrie TJ: Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clinical Infectious Diseases 2000; 31(6):1349-1356.
Pollack M: Pseudomonas aeruginosa. Principles and Practice of infectious diseases. 1995:1980-2003.
Blanc DS, Petignat C, Janin B, Bille J and Francioli P: Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clinical microbiology and infection 1998; 4(5):242-247.
Pechère JC and Köhler T: Patterns and modes of β -lactam resistance in Pseudomonas aeruginosa. Clinical microbiology and infection 1999; 5:S15-S18.
Press JB. Biodiversity: exciting prospects for drug discovery and development. Chemtracts organic chemistry 1996; 9:286-298.
Ojala T, Remes S, Haansuu P, Vuorela H, Hiltunen R, Haahtela K, Vuorela P. Antimicrobial activity of some coumarin containing herbal plants growing in Finland. Journal of ethnopharmacology 2000; 73(12):299-305.
Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406(6799):959-964.
Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other non-fermentative gram-negative bacteria. Clinical Infectious Diseases 1998; 27(Supplement_1):S93-S99.
Vaisvila R, Morgan RD, Posfai J and Raleigh EA: Discovery and distribution of super ‐ integrons among Pseudomonads. Molecular microbiology 2001; 42(3):587-601.
Tona L, Kambu K, Ngimbi N, Cimanga K and Vlietinck AJ. Antiamoebic and phytochemical screening of some Congolese medicinal plants. Journal of ethnopharmacology 1998; 61(1):57-65.
Henwood CJ, Livermore DM, James D, Warner M, Pseudomonas Study Group T. Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. Journal of Antimicrobial Chemotherapy 2001; 47(6):789-799.
Fraternale D, Flamini G, Ricci D. Essential oil composition and antimicrobial activity of Angelica archangelica L. (Apiaceae) roots. Journal of medicinal food 2014; 17(9):1043-1047.
Berenbaum MR, Nitao JK, Zangerl AR. Adaptive significance of furanocoumarin diversity inPastinaca sativa (Apiaceae). Journal of chemical ecology 1991; 17(1):207-215.
Weinmann I. History of the development and applications of coumarin and coumarin-related compounds. Coumarins: biology, applications and mode of action. John Wiley & Sons, Inc., New York, NY. 1997:122.
Tiina O: Biological Screening of Plant Coumarins. Academic Dissertation, University of Helsinki, Faculty of Science, Department of Pharmacy, Yliopistopaino, Helsinki, 2001; 21-22.
Yeh ML, Liu CF, Huang CL, Huang TC. Hepatoprotective effect of Angelica archangelica in chronically ethanol-treated mice. Pharmacology 2003; 68(2):70-73.
Published
How to Cite
Issue
Section
Copyright (c) 2020 Fatma A. Ibrahim, Noha A. Abd El-Latif, Manal S. Selim, Sahar S. Mohamed, Sherif A. A. Moussa
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at